Regeneron Pharmaceuticals shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $71M | 67k | 1050.94 |
| 2024-06-30 | $77M | 73k | 1050.72 |
| 2024-03-31 | $60M | 62k | 962.23 |
| 2023-09-30 | $59M | 71k | 822.57 |
| 2023-06-30 | $59M | 82k | 718.18 |
| 2023-03-31 | $85M | 103k | 821.37 |
| 2022-12-31 | $145M | 200k | 721.32 |
| 2022-09-30 | $180M | 261k | 688.73 |
| 2022-06-30 | $213M | 359k | 591.14 |
| 2022-03-31 | $300M | 429k | 698.32 |
| 2021-12-31 | $286M | 452k | 631.43 |
| 2021-09-30 | $320M | 530k | 605.11 |
| 2021-06-30 | $247M | 442k | 558.55 |
| 2021-03-31 | $201M | 425k | 473.14 |
| 2020-12-31 | $46M | 94k | 483.09 |
| 2020-09-30 | $54M | 96k | 559.78 |
| 2020-06-30 | $50M | 80k | 623.68 |
| 2020-03-31 | $1.7M | 3.6k | 488.36 |
| 2019-12-31 | $724k | 1.9k | 375.71 |
| 2019-09-30 | $256k | 923 | 277.36 |
| 2019-06-30 | $622k | 2.0k | 312.88 |
| 2019-03-31 | $2.0M | 4.8k | 410.45 |
| 2018-12-31 | $8.8M | 24k | 373.59 |
| 2018-09-30 | $8.5M | 21k | 404.12 |
| 2018-06-30 | $513k | 1.5k | 345.22 |
| 2017-12-31 | $76k | 202 | 376.24 |
| 2017-09-30 | $208k | 464 | 448.28 |
| 2017-06-30 | $735k | 1.5k | 491.31 |
| 2017-03-31 | $26k | 67 | 388.06 |
| 2016-12-31 | $81k | 218 | 371.56 |
| 2016-09-30 | $295k | 734 | 401.91 |
| 2016-06-30 | $657k | 1.9k | 348.91 |
| 2016-03-31 | $259k | 719 | 360.22 |
| 2015-12-31 | $390k | 719 | 542.42 |
| 2015-09-30 | $334k | 719 | 464.53 |
| 2015-06-30 | $367k | 719 | 510.43 |
| 2015-03-31 | $411k | 910 | 451.65 |
| 2014-12-31 | $373k | 910 | 409.89 |